Bristol-Myers Squibb Co.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $17.36B | $31.89B | $2.64B |
| FY2017 | $21.70B | $32.94B | $3.91B |
| FY2018 | $20.86B | $33.08B | $5.34B |
| FY2019 | $78.25B | $34.83B | $7.34B |
| FY2020 | $80.60B | $129.29B | $15.82B |
| FY2021 | $73.31B | $109.31B | $13.98B |
| FY2022 | $65.70B | $96.82B | $9.12B |
| FY2023 | $65.67B | $95.16B | $11.46B |
| FY2024 | $76.22B | $92.60B | $10.35B |
| FY2025 | $71.53B | $90.04B | $10.21B |